Metraipolis › archive › dc_519bae7ea2be

Reducing the low-prevalence effect with probe trials — Europe PMC PMID:41501239

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41501239
DOI: 10.1186/s41235-[numero omesso]-w
License (as archived): solo-consultazione
Archived: 2026-11-06T23:37:09.144Z
SHA-256 of the archived text: db339535e3ac8b1b8ff8485985c49b492faa7742a614b78d131e8731b6897dd3
Stable URL of this page: https://metraipolis.com/documento/dc_519bae7ea2be

How to cite

Reducing the low-prevalence effect with probe trials — Europe PMC PMID:41501239 — Europe PMC (en), https://europepmc.org/article/MED/41501239 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_519bae7ea2be (Metraipolis archive dc_519bae7ea2be, sha256 db339535e3ac8b1b8ff8485985c49b492faa7742a614b78d131e8731b6897dd3)

BibTeX

@misc{dc519bae7ea2be,
  title = {Reducing the low-prevalence effect with probe trials — Europe PMC PMID:41501239},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41501239},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_519bae7ea2be; sha256 db339535e3ac8b1b8ff8485985c49b492faa7742a614b78d131e8731b6897dd3},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41501239. Agents can read the archived copy with the MCP tool read_document.